ComptonMTShimRS, eds. The Social Determinants of Mental Health. Washington, DC: American Psychiatric Publishing; 2015. ISBN-13: 978-1-58562-477-5.
2.
ShimRSComptonMT. Addressing the social determinants of mental health: If not now, when? If not us, who?Psychiatric Serv. 2018;69:844–846. doi: 10.1176/appi.ps.201800060.
3.
DegenhardtLWhitefordHAFerrariAJ, et al.Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1564–1574. doi: 10.1016/S0140-6736(13)61530-5.
4.
VigoDThornicroftGAtunR. Estimating the true global burden of mental illness. Lancet Psych. 2016;3:171–178. doi: 10.1016/S2215-0366(15)00505-2.
5.
WhitefordHADegenhardtLRehmJ, et al.Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904), 1575–1586. doi: 10.1016/S0140-6736(13)61611-6
6.
InselTR. Assessing the economic costs of serious mental illness. Am J Psych. 2008;165(6):663–665. doi: 10.1176/appi.ajp.2008.08030366.
RoehrigC. Mental disorders top the list of the most costly conditions in the United States: $201 Billion. Health Aff. 2016;35(6):1130–1135. doi: 10.1377/hlthaff.2015.1659.
RuelEHauserRM. Explaining the gender wealth gap. Demography. 2013;50(4):1155–1176. doi: 10.1007/s13524-012-0182-0.
15.
ShawEHessCMChildersCHayesJ. Assets for Equity: Building Wealth for Women in Central Ohio; 2019. www.womensfundcentralohio.org. Accessed December 13, 2019.
LandryLJMercurioAE. Discrimination and women’s mental health: the mediating role of control. Sex Roles. 2009;61(3-4):192–203. doi: 10.1007/s11199-009-9624-6.
20.
KlonoffEALandrineHCampbellR. Sexist discrimination may account for well-known gender differences in psychiatric symptoms. Psychol Women Quart. 2000;24 (1):93–99. doi: 10.1111/j.1471-6402.2000.tb01025.x.
21.
AndaRFFelittiVJBremnerJD, et al.The enduring effects of abuse and related adverse experiences in childhood. a convergence of evidence from neurobiology and epidemiology. Eur Arch Psychiatry Clin Neurosci. 2006;256(3):174–86. doi: 10.1007/s00406-005-0624-4.
LamichhaneDKHeoYSKimHC. Depressive symptoms and risk of absence among workers in a manufacturing company: a 12-month follow-up study. Indust Health. 2018;56(3):187–197. doi: 10.2486/indhealth.2017-0065.
Evans-LackoSKnappM. Global patterns of workplace productivity for people with depression: absenteeism and presenteeism costs across eight diverse countries. Soc Psychiatry Psychiatr Epidemiol. 2016;51(11):1525–1537. doi: 10.1007/s00127-016-1278-4.
27.
BirnbaumHGWhiteAGSchillerMWaldmanTClevelandJMRolandCL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011;12(4):657–667. doi: 10.1111/j.1526-4637.2011.01075.x.
28.
Van HasseltMKeyesVBrayJMillerT. Prescription drug abuse and workplace absenteeism: evidence from the 2008–2012 National Survey on Drug Use and Health. J Workplace Behav Health. 2015;30(4):379392. doi: 10.1080/15555240.2015.1047499.